Is Predilife SA halal to invest in?

According to Musaffa's Shariah screening methodology, Predilife SA (ALPRE.PA) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Predilife SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Predilife SA using these criteria to determine its compliance status.

Can Muslims buy shares of Predilife SA?

Muslim investors may consider investing in Predilife SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Predilife SA classified as NOT HALAL?

Musaffa determines the Shariah status of Predilife SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Predilife SA updated?

The Shariah compliance status of Predilife SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Predilife SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Predilife SA?

You can check the latest Shariah compliance status of Predilife SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Predilife SA ALPRE.PA

€2.88 €0.01 (0.35%) 1D

Last Updated: May 15, 12:00 AM·XPAR

ALPRE.PA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 25, 2025

Report Source: 2024 Annual Report

Analyst's Ratings for Predilife SA (ALPRE.PA)

Based on 9 analysts giving stock ratings to Predilife SA in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Predilife SA. Stock Analysis ALPRE.PA

France Health Care Nano Cap Report: 2024 Annual

Predilife SA operates as a medical technology company. The company employs 27 full-time employees The company went IPO on 2018-12-21. The firm operates mainly in the field of oncology. Predilife offers MammoRisk, which is a predictive breast cancer test that combines medical imaging thanks to a proprietary software, DenSeeMammo, Big Data and statistics through a scoring tool and genetic profiles via a polygenic risk score (PRS). The image is analysed in order to extract the breast density and the first breast cancer risk factor. In addition, The technology used by MammoRisk makes it possible to evaluate from a database of individuals tracked over time, the risks of an individual to develop cancer compared to the fate of his/her closest neighbors through a database of a number of American and French women.

Key Statistics of Predilife SA (ALPRE.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€2.70€2.89

Today's Open

€2.89

Volume

760.00

P/E Ratio (TTM)

52 Week Range

€2.57€4.19

Market Cap

11.74M

Avg. Volume

723.95

Dividend Yield

Financial Metrics & Statements of Predilife SA (ALPRE.PA)

FAQ's for Predilife SA (ALPRE.PA)

According to Musaffa’s Shariah screening methodology, Predilife SA (ALPRE.PA) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.